Daniel L.farkas

Daniel L.Farkas, PhD is a Theoretical Physicist holding a PhD in Biophysics from the Weizmann Institute in Israel, where he was the honoree of the Yashinsky Prize, EMBO Fellowship, UNESCO Fellowship and Aharon Katchalsky-Katzir Award. Dr. Farkas was a Fulbright Scholar, conducting research at UCSD and U. of Washington and a Fulbright lecturer at UC Berkeley. He joined Carnegie Mellon University in 1989 and led a National Science & Technology Center (1996-2002) that received the Smithsonian Award for Science, while also Professor of Bioengineering at the University of Pittsburgh. In 2002 he joined Cedars-Sinai Medical Center in Los Angeles as Vice-chairman for Research & Director of the Minimally Invasive Surgical Technologies Institute, and Professor of Surgery & Biomedical Sciences. Dr. Farkas is currently Research Professor of BME at USC. His interests center on the investigation of the living state with light, for applications in biology, biotechnology, BME and medicine. Biophotonic Imaging is his main technology focus area, with primary applications in minimally invasive surgery, regenerative medicine and especially innovative cancer and neuroscience research, pursued at the mesoscopic level. His work has resulted in more than 200 peer-reviewed publications and 32 books edited, supported by $80M government funding. Dr. Farkas has chaired 34 international scientific conferences, is on the Executive Committee of the Biomedical Optics Society, served on 11 journal editorial boards, 20+ NSF panels and NIH Study Sections, and on scientific advisory boards of national research centers, international organizations, high-tech and biomedical companies. He was awarded the Automated Imaging Association Award for Scientific Application, the Sylvia Sorkin Greenfield Award, American Association of Physicists in Medicine, and elected President of IMLAS, an international surgical society. Recently he was named Global Good Fellow by Bill Gates to work on advanced technologies for addressing Third World challenges. Dr. Farkas founded ten successful high/bio-tech startups, three acquired by larger companies and one currently on the NYSE.